Vivos Therapeutics, Inc.VVOSNASDAQ
Loading
Revenue Growth AcceleratingAccelerating
Percentile Rank100
3Y CAGR+274.1%
5Y CAGR+162.4%
Year-over-Year Change
Year-over-year revenue growth rate
3Y CAGR
+274.1%/yr
Quarterly compound
5Y CAGR
+162.4%/yr
Recent acceleration
Percentile
P100
Near historical high
vs 5Y Ago
124.3x
Strong expansion
Streak
2 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q3 2025 | 77.57% |
| Q2 2025 | 26.66% |
| Q1 2025 | -18.44% |
| Q4 2024 | -4.20% |
| Q3 2024 | -4.79% |
| Q2 2024 | 18.57% |
| Q1 2024 | 5.26% |
| Q4 2023 | -1.61% |
| Q3 2023 | -2.77% |
| Q2 2023 | -11.98% |
| Q1 2023 | -2.35% |
| Q4 2022 | -6.97% |
| Q3 2022 | 1.48% |
| Q2 2022 | 20.92% |
| Q1 2022 | -21.26% |
| Q4 2021 | -3.33% |
| Q3 2021 | 1.09% |
| Q2 2021 | 30.42% |
| Q1 2021 | 4.26% |
| Q4 2020 | 0.47% |
| Q3 2020 | 0.62% |
| Q2 2020 | 2.34% |
| Q1 2020 | 4.61% |
| Q4 2019 | -7.84% |
| Q3 2019 | 32.06% |
| Q2 2019 | -0.00% |
| Q1 2019 | 0.00% |